Labcorp to offer risk-scoring test for people with advanced liver fibrosis due to NASH

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 26, 2022-- For the millions of people in the United States living with an advanced form of chronic liver disease, simply understanding the potential for future complications could help stave off severe damage and even a transplant. Labcorp (NYSE: LH), a leading global life sciences company, is making this possible by offering the Enhanced Liver Fibrosis (ELF™) test. Developed by Siemens Healthineers, the physician-ordered blood test helps assess the risk of disease progression in individuals—opening the door for improved outcomes. The test has been granted De Novo marketing authorization by the U.S. Food and Drug Administration .

Ovia Health and CDPHP: Supporting healthy parenthood for members

Cardiff, UK, March 3, 2021 ‒ TrakCel, a leading supplier of cellular orchestration solutions supporting the cell and gene therapy industry, today announces that it has closed its latest funding round led by AmerisourceBergen and Labcorp (NYSE: LH). These strategic investments enable further transformation of TrakCel’s cellular therapy orchestration solution, growth of its existing partner ecosystem, and continued global expansion. 

Xcellbio announces $27.5 million Series B financing

SAN FRANCISCO, Jan. 19, 2022 — Xcell Biosciences, Inc. (“Xcellbio”), a leading developer of innovative technologies and platforms designed to further the research, development, and manufacturing of cell and gene therapies, today announced $27.5 million in Series B financing led by Casdin Capital. Also participating in this financing are new investors Dynamk Capital, Formic Ventures, and Labcorp, as well as existing investors HBM Genomics and Viking Global Investors. In connection with the financing, Shaun Rodriguez, PhD, Director of Life Science Research at Casdin Capital, will join the Xcellbio board of directors.

MentorcliQ Names Labcorp’s Mary Schlegel as its first “Diversity ChangeMaker of the Year”

COLUMBUS, Ohio, Jan. 18, 2022 — Today, MentorcliQ, the leader in employee mentoring software, announced Mary Schlegel, learning and development manager at leading global life sciences company Labcorp, as the MentorcliQ 2021 Diversity ChangeMaker of the Year. The award is presented to an individual who has leveraged mentoring within their organization to create a greater sense of acceptance, belonging and community for all employees. The winner has also helped to foster positive social change and embodies the idea that all workplaces should promote diversity, equity, and inclusion (DEI) for the benefit of everyone.